Exploring new ways to inhibit HIV infection and find a cure for AIDS
Pittsburgh Center for HIV Protein Interactions (PCHPI)
This study is looking at how HIV proteins interact with our body's cells to find new ways to stop the virus from spreading, which could lead to better treatments for people living with HIV/AIDS.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11078362 on NIH RePORTER |
What this research studies
This research focuses on understanding the interactions between HIV proteins and host cell components to identify new targets for inhibiting HIV-1 infection. By studying the structural characteristics of HIV-1 proteins and their complexes, the research aims to uncover mechanisms of HIV assembly, entry, and integration into host cells. The project involves collaborative efforts across multiple scientific disciplines, utilizing advanced techniques such as cryo-electron microscopy and nuclear magnetic resonance to gain insights into the virus's behavior and resistance mechanisms. Patients may benefit from the development of novel therapeutic strategies that could improve treatment outcomes for HIV/AIDS.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living with HIV/AIDS, particularly those experiencing challenges with drug resistance or long-term antiretroviral therapy.
Not a fit: Patients who are not infected with HIV or those who do not have any complications related to HIV/AIDS may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively suppress HIV and potentially cure AIDS.
How similar studies have performed: Previous research has shown promise in targeting HIV protein interactions, indicating that this approach could lead to significant advancements in HIV treatment.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Gronenborn, Angela M. — University of Pittsburgh at Pittsburgh
- Study coordinator: Gronenborn, Angela M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.